You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2025 › November › 14
Merck
8 months ago
Merck will acquire Cidara Therapeutics in a nearly $9.2 billion deal, the companies said on Friday, gaining access to an experimental drug for flu prevention.
Merck nears deal for flu-prevention biotech Cidara ⊖
San Diego company’s lead drug is a potential alternative to vaccines for vulnerable patients
page 1 of 1